Literature DB >> 24948533

Reliability and validity of the C-BiLLT: a new instrument to assess comprehension of spoken language in young children with cerebral palsy and complex communication needs.

Joke J Geytenbeek1, Lidwine B Mokkink, Dirk L Knol, R Jeroen Vermeulen, Kim J Oostrom.   

Abstract

In clinical practice, a variety of diagnostic tests are available to assess a child's comprehension of spoken language. However, none of these tests have been designed specifically for use with children who have severe motor impairments and who experience severe difficulty when using speech to communicate. This article describes the process of investigating the reliability and validity of the Computer-Based Instrument for Low Motor Language Testing (C-BiLLT), which was specifically developed to assess spoken Dutch language comprehension in children with cerebral palsy and complex communication needs. The study included 806 children with typical development, and 87 nonspeaking children with cerebral palsy and complex communication needs, and was designed to provide information on the psychometric qualities of the C-BiLLT. The potential utility of the C-BiLLT as a measure of spoken Dutch language comprehension abilities for children with cerebral palsy and complex communication needs is discussed.

Entities:  

Keywords:  Cerebral palsy; Complex communication needs; Language comprehension; Language test; Reliability; Validity

Mesh:

Year:  2014        PMID: 24948533     DOI: 10.3109/07434618.2014.924992

Source DB:  PubMed          Journal:  Augment Altern Commun        ISSN: 0743-4618            Impact factor:   2.214


  8 in total

1.  Longitudinal Development of Receptive Vocabulary in Children with Cerebral Palsy and Anarthria: Use of the MacArthur-Bates CDI.

Authors:  Michael Molinaro; Aimee Teo Broman; Paul J Rathouz; Katherine C Hustad
Journal:  Dev Neurorehabil       Date:  2019-07-29       Impact factor: 2.308

2.  Longitudinal growth of receptive language in children with cerebral palsy between 18 months and 54 months of age.

Authors:  Katherine C Hustad; Ashley Sakash; Aimee Teo Broman; Paul J Rathouz
Journal:  Dev Med Child Neurol       Date:  2018-05-22       Impact factor: 5.449

3.  Functional Communication Abilities in Youth With Cerebral Palsy: Association With Impairment Profiles and School-Based Therapy Goals.

Authors:  Clare Koopmans; Ashley Sakash; Jennifer Soriano; Helen L Long; Katherine C Hustad
Journal:  Lang Speech Hear Serv Sch       Date:  2021-11-12       Impact factor: 2.215

4.  Assessment and management of the communication difficulties of children with cerebral palsy: a UK survey of SLT practice.

Authors:  Rose Mary Watson; Lindsay Pennington
Journal:  Int J Lang Commun Disord       Date:  2015-02-04       Impact factor: 3.020

5.  A validation and acceptability study of cognitive testing using switch and eye-gaze control technologies for children with motor and speech impairments: A protocol paper.

Authors:  Petra Karlsson; Ingrid Honan; Seth Warschausky; Jacqueline N Kaufman; Georgina Henry; Candice Stephenson; Annabel Webb; Alistair McEwan; Nadia Badawi
Journal:  Front Psychol       Date:  2022-09-26

6.  The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial.

Authors:  Laura A Bonouvrié; Jules G Becher; Johan S H Vles; R Jeroen Vermeulen; Annemieke I Buizer
Journal:  Ann Neurol       Date:  2019-05-21       Impact factor: 10.422

7.  Use of the Dyskinesia Impairment Scale in non-ambulatory dyskinetic cerebral palsy.

Authors:  Helga Haberfehlner; Laura A Bonouvrié; Karin Boeschoten; Sabine Fleuren; Elegast Monbaliu; Jules G Becher; R Jeroen Vermeulen; Annemieke I Buizer
Journal:  Dev Med Child Neurol       Date:  2019-11-29       Impact factor: 5.449

Review 8.  Factors associated with spoken language comprehension in children with cerebral palsy: a systematic review.

Authors:  Emma Vaillant; Johanna J M Geytenbeek; Elise P Jansma; Kim J Oostrom; R Jeroen Vermeulen; Annemieke I Buizer
Journal:  Dev Med Child Neurol       Date:  2020-08-27       Impact factor: 5.449

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.